Contineum Therapeutics Inc

For the period ended Dec 31, 2024. Filed Mar 6, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 6, 2025

CTNM$10.30+8.2%Stored close · as of Nov 9, 2026

Opening this filing…